Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Cancer Research|October 18, 2002
Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphomaJohn M Timmerman, Gita Singh, Gary Hermanson, et al.Biomacromolecules|June 24, 2022
Fingolimod-Conjugated Charge-Altering Releasable Transporters Efficiently and Specifically Deliver mRNA to Lymphocytes In Vivo and In VitroStefano Testa, Ole A W Haabeth, Timothy R Blake, et al.The Journal of Clinical Investigation|March 30, 2018
Imaging activated T cells predicts response to cancer vaccinesIsrat S Alam, Aaron T Mayer, Idit Sagiv-Barfi, et al.Blood|September 8, 2023
Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptorSarah Haebe, Grady Day, Debra K Czerwinski, et al.Blood|March 17, 2021
Single-cell analysis can define distinct evolution of tumor sites in follicular lymphomaSarah Haebe, Tanaya Shree, Anuja Sathe, et al.Blood|January 9, 2013
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cellsJune H Myklebust, Jonathan M Irish, Joshua Brody, et al.Biorxiv : the Preprint Server for Biology|April 21, 2021
An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memoryOle A W Haabeth, Julian J K Lohmeyer, Adrienne Sallets, et al.ACS Central Science|August 3, 2021
An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releasable Transporters with a TLR-9 Agonist Induces Neutralizing Antibodies and T Cell MemoryOle A W Haabeth, Julian J K Lohmeyer, Adrienne Sallets, et al.Blood|December 29, 2018
Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpointsNoemi Andor, Erin F Simonds, Debra K Czerwinski, et al.Cancer Discovery|August 30, 2018
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent LymphomaMatthew J Frank, Patrick M Reagan, Nancy L Bartlett, et al.Pageof 5